Answer ALS is backing a Louisiana collaboration aimed at using AI to accelerate drug discovery for ALS and other ...

HealthDay News — Artificial intelligence (AI) support improves radiologists’ breast cancer detection accuracy when reading mammograms, according to a study published online July 8 in Radiology.

Tevogen ('Tevogen Bio Holdings Inc.” or 'Company”) (Nasdaq: TVGN), today welcomes the White House’s release of 'Winning the ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...

Investing.com -- PTC (NASDAQ: PTC) Therapeutics (NASDAQ: PTCT) stock rose 9% after the company announced that the U.S. Food and Drug Administration (FDA) has approved its drug SEPHIENCE (sepiapterin) ...

Disc Medicine, Inc. (NASDAQ:IRON) is a clinical-stage biopharmaceutical company focused on developing innovative treatments ...

Mrs. Doubtfire’ star says it would be ‘so cool’ to revive Robin Williams’ iconic voice with AI for new projects ...

Organ transplantation remains the most effective treatment for end-stage diseases. However, persistent challenges such as organ shortage, immune rejection, ...

Verona Pharma plc (NASDAQ:VRNA) is one of the best multibagger stocks according to hedge funds. On July 9, 2025, Merck & Co.

An announcement from PTC Therapeutics ( (PTCT) ) is now available. On July 28, 2025, PTC Therapeutics announced that the FDA approved Sephience™ (sepiapterin) for treating phenylketonuria (PKU) in ...

An unregulated drug sold in gas stations and derived from a southeast Asian tree will become illegal next month. Here’s what ...